Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 1905-1913, August 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arai, K.
Right arrow Articles by Blakemore, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arai, K.
Right arrow Articles by Blakemore, W. S.

Haptenic Activity of L-Phenylalanine Mustard1

Kazuhiko Arai, Herbert W. Wallace and William S. Blakemore

Department of Surgery, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104

The immunological activity of an alkylating anticancer agent, L-phenylalanine mustard (PhM), was studied by hemagglutination, gel immunodiffusion, and counterimmunoelectrophoresis techniques. Wistar rats immunized with PhM-conjugated syngeneic normal tissue protein produced PhM-specific humoral antibodies. Rats of the same strain immunized with PhM-conjugated extract of Walker 256 carcinosarcoma produced carrier protein-, hapten-, and conjugate-specific antibodies. In comparative studies of Wistar and Fischer rats and New Zealand White rabbits immunized with PhM-conjugated extracts of Walker 256 or human tumors, a common PhM-specific antibody was detected in sera from the animals, regardless of the strain or species and regardless of the origin of the carrier protein. Intratumoral or intradermal injection of PhM that had not been conjugated with a protein moiety induced a PhM-specific antibody in Wistar rats with and without tumor. These results indicate that PhM may act against tumor by immunological as well as cytochemical mechanisms.

1 This work was supported in part by Grant RR-00322 from the General Clinical Research Centers Program of the Division of Research Resources, NIH, and by American Cancer Society Institutional Grant IN-38-L.

Received 10/24/72. Accepted 5/ 4/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.